Michael poon, m.d.

Curriculum Vitae
Michael Poon, M.D.
Michael Poon, MD FACC
Director of Advanced Cardiovascular Imaging
Stony Brook University Medical Center
Stony Brook, NY 11794
631-444-9565
[email protected]

ACADEMIC APPOINTMENTS:

1993-95
Instructor of Medicine, Mount Sinai School of Medicine
1995-2003
Assistant Professor of Medicine (Cardiology), Mount Sinai School of
Medicine
2003-2009
Associate Professor of Medicine (Cardiology), Mount Sinai School of
Medicine
Professor of Radiology and Medicine (Cardiology), Stony Brook
School of Medicine

HOSPITAL APPOINTMENT:
1993-95
Assistant Attending, Mount Sinai Hospital
2003-2009
Associate Attending, Mount Sinai Hospital
2003-2009
Director of Cardiology, Cabrini Medical Center, New York, NY
Director of Advanced Cardiovascular Imaging, Stony Brook
University Hospital, Stony Brook, NY

EDUCATION:

1983 B.S. Polytechnic Institute of New York (degree summa cum laude)

1987 M.D. Mount Sinai School of Medicine

POSTDOCTORAL TRAINING:

Internship and Residency

Intern in Medicine, Mount Sinai Hospital, New York, NY
Resident in Medicine, Mount Sinai Hospital, New York, NY
Clinical Fellowship
1990-93

Fellow in Cardiology, Mount Sinai Hospital, New York, NY


CERTIFICATION:

1998

Diplomat, National Board of Medical Examiners No. 338025
Diplomat, American Board of Internal Medicine. No. 130374
Certified in ECG reading by American College of Cardiology
Diplomat, American Board of Internal Medicine, Cardiovascular

LICENSURE:

1988

The University of the State of New York No. 175234-1
2005 The University of the State of New Jersey No. 25MA07870800


HONORS/AWARDS:

1982

Who’s Who Among Students in America Colleges & Universities
President of the local chapter of Tau Beta Pi (National Engineering
Honor Society), Polytechnic Institute of New York.
Summer Research Award, Brookhaven National Laboratory.
Student Summer Research Award, National Institute of Health.
Department of Medicine’s Annual Research Day Award, Mount Sinai
Hospital.
Dr. Herman C.B. and Suzanna Denber Award for excellence in
Cardiology Research, Mount Sinai Hospital.
Clinician-Scientist Award, American Heart Association.
Arthur Ross Scholarship in Cardiovascular Medicine, Mount Sinai
Hospital.
Irvine H. Page Arteriosclerosis Research Award for Young
Investigators (Finalist), American Heart Association.
Young Investigator Award in the Category of Molecular & Cellular
Cardiology (Finalist), American College of Cardiology.
Young Investigator Award in Vascular Biology ‘98 (Winner),
American Heart Association and North American Vascular Biology
Organization.
Excellence in teaching award, Emergency Department, Mount Sinai
Hospital
Attending of the Year for Excellence in Teaching, Cabrini Medical
Excellence in Utilization of Services For commitment and Successful
Efforts in Decreasing Length of Stay, Cabrini Medical Center

OTHER PROFESSIONAL APPOINTMENTS:

Member, American Heart Association Councils on Basic Science and
Circulation
Member, Alpha Omega Alpha (AOA) Honor Medical Society
Fellow, American Heart Association Council on Arteriosclerosis,
Thrombosis, and Vascular Biology
Fellow, American College of Cardiology (ACC)
Director, The Mount Sinai Pulmonary Hypertension Program
Medical Director, Joseph H. Hazen Ambulatory Cardiac Care Center,
Mount Sinai Hospital
Member, Support Group Leaders, Pulmonary Hypertension
Association (PHA)
2001-03 Medical Director, Cardiac MR Imaging Program
The Zena & Michael A. Wiener Cardiovascular Institute
Member, Society for Cardiovascular Magnetic Resonance
2002 Member, Mount Sinai Institutional Review Board
Director, Clinical Cardiac MR and CT Imaging Program, Mount Sinai
School of Medicine
Member, Cabrini Medical Center Institutional Review Board
President-Elect and Chairman of the Advocacy Committee, Society
for Cardiovascular CT
Member, CPT Coding Committee of the American College of
Cardiology
President-Elect, Society of Cardiovascular Computed Tomography
Chairman of the Advocacy Committee, Society of Cardiovascular
Computed Tomography

Editorial Board
2003-

Congestive Heart Failure, Le Jacq Communications

Scientific Advisory Board
2002-

Chase Medical
Siemens Medical Solutions Cardiac CT and MR Imaging

TRAINING RECORD:
YEAR

NAME
CURRENT POSITION PLACE OF EMPLOYMENT
Vascular Biology
William C. Hsu, MD
Instructor of Medicine Yale University Medical Center

1993-5 Arthur Lee, MD Cardiologist Beth Israel Medical Center, NY
1993-9

Bin Liu, MD
Research Associate
Mount Sinai Medical Center, NY
1996-8 Jason Cohen, BS
Medical Student Sacklar School of Medicine
Ronald Lee, MD
Chief Medical Resident Mount Sinai Medical Center, NY

Pulmonary Hypertension
1995-2001

Kevin Dunsky, MD
Instructor of Medicine Presbyterian Hospital, NY
Daniel Jacoby, MD
Chief Medical Resident Mount Sinai Medical Center, NY
Erik Altman, MD
Medical Resident Mount Sinai Medical Center, NY
Roxanna Sulica, MD
Instructor Mount Sinai Medical Center, NY
Howard Dinh, MD
Cardiology Fellow
UCLA Medical Center

Cardiac MR/CT Imaging
2001-2

Angela Berning, MD MR Radiologist
University of Melbourne, Australia
Adam Rosenbluth, MD Attending Cardiologist Mount Sinai Medical Center, NY
Howard Dinh, MD
Cardiology Fellow
UCLA Medical Center
Javier Sanz, MD Cardiac MRI/CT Fellow Mount Sinai Medical Center, NY

2002-3 Theresa Rios, MD Cardiac MRI/CT Fellow Barcelona, Spain
2003

Paola Kirchnir, MD
Cardiac MR/CT Fellow Buenos Aires, Argentina
Rafael Salguero, MD Cardiac Fellow Madrid, Spain
Michael Mancina, MD Attending Cardiologist Kansas City, MO
Thomas Raya, MD
Attending Cardiologist St Paul, MN
C.K. Luk, MD
Attending Cardiologist Hong Kong, China


TEACHING ACTIVITIES:

1993-2001
Preceptor for the medical student physical examination course

1993-2001

Preceptor for the medical student Cardiology elective

1993-1997

Course Director, Third and Fourth Year Medical Student Cardiology
Elective at Mount Sinai School of Medicine 1993-1997


1997-1999

Lecturer, Monthly Lectures on Electrocardiogram Interpretation for
the Emergency Department at Mount Sinai Hospital


1999-2001

Course Director, Cardiology elective for the international exchange
physicians and students at Mount Sinai Hospital

Course Director, 3rd Preceptorship for Advanced Cardiovascular
Education, Supported by Bristol-Myers-Squibb/Sanofi

Course Director, Cardiovascular MR/CT Imaging: State of the Art
2001 update

Supported by the International Institute for Continuing Medical
Education, Inc.


2002
Course Director, Cardiovascular MR/CT Imaging: State of the Art
2002 update

Supported by the International Institute for Continuing Medical
Education, Inc.


2003
Course Co-Chairman, New York Cardiovascular MR/CT Imaging
Symposium.
Supported by Siemens Medical


2003 Director of Cardiology Consult and Elective (Internal Medicine
Program), Cabrini Medical Center
2005

Co-Director of the Program Committee of the North American Society
of Cardiac Imaging Annual Scientific Meeting (NASCI)

GRANT SUPPORT:


Past Grants:

1. Clinician-Scientist Award (No. 93004390) 7/1/1993-6/30/98
American Heart Association
$400,000
“Post-transcriptional Regulation of JE/MCP-1 mRNA by Glucocorticoids”
P.I. Michael Poon.
2. Arthur Ross Scholarship in Cardiovascular Medicine 7/1/1995-6/30/1998 10%
Arthur Ross Foundation
“Regulation of JE/MCP-1 in Vascular Smooth Muscle Cells”
P.I. Michael Poon.
Current Grants:
1. SCOR on Thrombosis
2/1/2001-1/31/2006 5%
$550,000
“Tissue Factor Thrombosis in the Arterial Wall”
P.I.: Valentin Fuster
Co-investigator:Michael Poon
2.Pulmonary Hypertension
7/1/1997-present 5%
Cardiovascular Institute Research Fund
“MR imaging for Primary Pulmonary Hypertension”
Chasanoff Research Foundation
$25,000/year
P.I.: Michael Poon
3. EPIX MS-325-13 7/1/2002 – present 5%
“Safety and Efficacy of MS-325 Enhanced MRA in Patients with Suspected
Peripheral Vascular Disease”
$10,000 total
P.I.: Michael Poon
4. MSSM Consortium for Cardiovascular Imaging Technology (MCCIT)
“Comparison of Ultrafast-CT coronary angiography and Cardiac MRI with X-ray”
7/1/2002 – present 5%
GlaxoSmithKline and Schering $230,000/year
P.I.: Michael Poon
5. The role of Natrecor in the acute treatment of right ventricular failure
SCIOS Inc.
12/1/2002 - present 5%
P.I.: Michael Poon
Co-PI: Roxana Sulica
6. Bosentan in Pulmonary Sarcoidosis 12/1/2003 – present 5%
Acetelion Inc.
$100,000
P.I.: Roxana Sulica
Co-PI: Michael Poon
(Original Peer-Reviewed Articles)

1. Poon, M., Cronin, DC., Wormser, G.P., Bottone, E.J.
In vitro susceptibility of Cryptococcus neoformans Isolates from patients with
Acquired Immunodeficiency Syndrome (AIDS).
Arch Pathol Lab Med (1988) 112:161-162.
2. Poon, M., Megyesi, J., Green, R.S., Zhang, H., Rollins, R.J., Safirstein R., Taubman,
In vivo and in vitro inhibition of JE gene expression by glucocorticoids.
J. Biol. Chem. (1991) 266:22375-379.
3. Safirstein, R., Megyesi, J., Saggi, SJ., Price, PM., Poon, M., Rollins, BJ., Taubman,
Expression of cytokine-like genes, JE and KC, is increased during renal ischemia.
Am J Physiol (1991) Dec; 261(6 Pt 2):F1095-F1101.
4. Taubman,MB., Rollins,BJ., Poon, M., Marmur JD., Green, RS., Berk, BC., Nadel-
JE mRNA accumulates rapidly in aortic injury and in PDGF-stimulated vascular
smooth muscle cells.
Circ. Res. (1992) Feb;70(2):314-25.
5. Marmur, JD., Poon, M., Taubman MB.
Induction of PDGF-responsive genes in vascular smooth muscle: Implications for
the early response to vessel injury.
Circulation (1992) Dec;86(6 Suppl): III 53-60.
Original Peer-Reviewed Articles (continued):
6. Harpel, P.C., Poon, M., Zhang, X., Taubman, M.B.
Lipoprotein(a): searching for a function.
Trans. Am. Clin. Climatol. Assoc. (1995) 107:125-133
7. Poon, M., Marx, S.O., Taubman, M.B., Marks, A.R.
Rapamycin inhibits vascular smooth muscle cells migration.
J. Clin. Invest. (1996) 98:2277-2283.
8. Poon, M., Hsu W.C., Bogdanov V.Y., Taubman, M.B.
Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle
cells in response to PDGF is due predominantly to the induction of JE/MCP-1.
Am. J. of Pathol. (1996) 149:307-317.

9. Poon, M., Zhang X., Dunsky K.G., Taubman, M.B., Harpel, PC.
Apolipoprotein(a) induces monocyte chemotactic activity in human vascular
endothelial cells.
Circulation (1997) 96:2514-2519.
10. Poon M., Zhang X., Dunsky K.G., Taubman M.B, Harpel P.C.
Apolipoprotein(a) is a human vascular endothelial cell agonist: studies on the
induction in endothelial cells of monocyte chemotactic factor activity
Clin. Genet. (1997) 52:308-313
11. Fuster, V., Poon, M., Willerson, J.T.
Learning From the Transgenic Mouse: Endothelium, Adhesive Molecules, and
Neointimal Formation.
Circulation (1998) Jan 6-13;97(1):16-18.
Original Peer-Reviewed Articles (continued):

12. Bogdanov, V.Y., Poon, M., Taubman, M.B.
Platelet-derived growth factor-specific regulation of the JE promoter in rat aortic
smooth muscle cells.
J. Biol. Chem. (1998) Sep 18; 273(38): 24932-8.
13. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ,
Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive In Vivo High-Resolution Magnetic Resonance Imaging of
Atherosclerotic Lesions in Genetically Engineered Mice.
Circulation (1998) Oct 13;98(15):1541-7.
14. Poon M., Liu B, Taubman MB.
Identification of a Novel Dexamethasone-Sensitive RNA-Destabilizing Region on
Rat Monocyte Chemoattractant Protein 1 mRNA.
Mol. Cell. Biol. (1999). 19:6471-6478.
15. Poon M., Cohen J, Asiddiqui Z, Fallon JT, Taubman MB.
Trapidil inhibits monocyte chemotactic protein-1 and macrophage accumulation
after balloon arterial injury in rabbits.
Lab. Invest. (1999). 19:1-7.
16. Haque NS, Zhang X, French DL, Li J, Poon M, Fallon JT, Gabel BR,
CC chemokine I-309 is the principal monocyte chemoattractant induced by
apolipoprotein(a) in human vascular endothelial cells.
Circulation (2000) Aug 15;102(7):786-92


Original Peer-Reviewed Articles (continued):

17. Horn EM, Barst RJ, Poon M.
Letter to the Editor: Epoprostenol for Treatment of Pulmonary
Hypertension in Patients with Systemic Lupus Erythematosus.
Chest (2000). Oct; 118(4):1229-30.
18. Poon M., Gertz D, Fallon JT, Wiegman P, Berman JW, Sarembock IJ, Taubman
MB. Dexamethasone inhibits macrophage accumulation after balloon arterial
injury in cholesterol fed rabbits.
Atherosclerosis (2001). Apr;155(2):371-80.
19. Ji S, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE.
A Role for p27kip1 in Vascular Smooth Muscle Cell Migration.
Circulation (2001) Jun 19;103(24):2967-72
20. Poon, M., Badimon, J.J., Fuster, V.
Overcoming restenosis with sirolimus: from alphabet soup to clinical
reality.
Lancet. 2002 Feb 16;359(9306):619-22.
21. Desai U.A., Deo S.K., Hyland K., Poon M., Daunert S.
Bioluminescent Immunoassay for 6-keto-prostaglandin F1α: Application in
the Determination of Prostacyclin in Patients with Primary Pulmonary
Hypertension.
Anal. Chem. 74, 3892-3898, 2002
Original Peer-Reviewed Articles (continued):

22. Poon M. Fuster V., Fayad Z.
Cardiac magnetic resonance imaging: a "one-stop-shop" evaluation of
myocardial dysfunction.
Curr Opin Cardiol. 2002 Nov;17(6):663-70.
Original Peer-Reviewed Articles (continued):

23. Srock K., Dubin-Kerr L., Poon M., Fallon JT.
Refractory Pulmonary Hypertension in a Lupus Patient with Occult
Pulmonary Vasculitits
Clinical Rheumatology. 2003 August; 9(4) 263-266.
24. Nikolaou K., Poon M., Sirol M., Becker CM., Fayad Z.
Complementary results of computed tomography and magnetic resonance
imaging of the heart and coronary arteries: a review and future outlook.
Cardiol Clin. 2003 Nov;21(4):639-55.
25. Sanz J, Rius T, Kuschnir P, Bodes RS, Poon M.
Assessment of myocardial ischemia and viability using cardiac magnetic
resonance.
Curr Cardiol Rep. 2004 Jan;6(1):62-9.

26. Sulica R, Poon M.
Current medical treatment of pulmonary arterial hypertension.
Mt Sinai J Med. 2004 Mar;71(2):103-14.

Original Peer-Reviewed Articles (continued):

27. Viles-Gonzalez JF, Anand SX, Valdiviezo C, Zafar MU, Hutter R, Sanz J, Rius T, Poon M, Fuster V, Badimon JJ.
Update in atherothrombotic disease.
Mt Sinai J Med. 2004 May;71(3):197-208.
28. Sanz J, Poon M.
Evaluation of ischemic heart disease with cardiac magnetic resonance and
computed tomography.
Expert Rev Cardiovasc Ther. 2004 Jul;2(4):601-15.
Original Peer-Reviewed Articles (continued):

29. Sanz J. Poon M.
New MRI sets the gold standard for predicting cardiac viability.
Hospital Healthcare Europe: Cardiology. 2004-4: 1-4
30. Sanz J, Rius T, Kuschnir P, Macaluso F, Fuster V, Poon M.
Images in cardiovascular medicine. Double-chambered left ventricle: complete characterization by cardiac magnetic resonance and multidetector-row Circulation. 2004 Nov 16;110(20):e502-3.
31. Sulica R, Emre S, Poon M.
Medical management of porto-pulmonary hypertension and right heart failure prior to living-related liver transplantation. Congest Heart Fail. 2004 Jul-Aug;10(4):192-4.
Original Peer-Reviewed Articles (continued):

32. Sanz J, Rius T, Kuschnir P, Fuster V, Goldberg J, Ye XY, Wisdom P, Poon M.
The importance of end-systole for optimal reconstruction protocol of coronary angiography with 16-slice multidetector computed tomography. Invest Radiol. 2005 Mar;40(3):155-63.
33. Nikolaou K, Sanz J, Poon M, Wintersperger BJ, Ohnesorge B, Rius T, Fayad ZA,
Assessment of myocardial perfusion and viability from routine contrast- enhanced 16-detector-row computed tomography of the heart: preliminary Eur Radiol. 2005 May;15(5):864-71. Epub 2005 Mar 18.
34. Sulica R, Poon M.
Medical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-based medicine. Expert Rev Cardiovasc Ther. 2005 Mar;3(2):347-60.
Publications: (chapters in books)

1. Rayfield, EJ. and Poon, M.
The nature of diabetes mellitus-viral infection and other factors.
In Davidson, J.K. (ed.) Clinical Diabetes Mellitus: a problem oriented approach.
2nd ed. Thieme, New York, N.Y. 1991, pp. 50-57. 2. Masci, JR., Poon, M., Wormser, GP., and Bottone EJ.
Cryptococcus neoformans infections in the era of AIDS.
in Wormser, G.P. (ed.) AIDS and other manifestations of HIV Infection, 2nd ed.
3. Taubman, MB., Poon, M., Marmur JD., Wax, SD.
Gene induction in vessel wall injury:implications for restenosis after angioplasty.
In Woodford F.P., Davignon J., Sniderman A. (ed) Atherosclerosis X. Elsevier
4. Rayfield, EJ. and Poon, M.
Pathogenesis of diabetes mellitus-viral infection and other factors.
In Davidson, J.K. (ed.) Clinical Diabetes Mellitus: a problem oriented approach.
3nd ed. Thieme, New York, N.Y. 1998, pp. 50-57. 5. Marin M, Hollier L, Poon, M., Fuster V.
Advances in the minimally invasive treatment of peripheral vascular disease
In Fuster V. (ed) Hurst’s The Heart, McGraw Hill 2000, pp. 2471-2483.
Publications: (chapters in books) (continued):

6. Poon, M., Rayfield EJ.
Diabetes and its vascular complications.
In Toprol EJ. Theory and Practice of Vascular Medicine. Springer-Verlag, (2002) (in
7. Dinh H. Goldman JP, Poon M.
MRI in the Assessment of Pulmonary Hypertension
In MRI of the Cardiovascular System, ed by Albert Lardo, Zahi Fayad, Nicolos
8. Yang PC., Poon M., Vitarius JA., Pohost GM.
Cardiac MR Imaging
In Atherosclerosis and Coronary Artery Disease,
2nd edition, Ed by Valentin Fuster, Eric Toprol, and Elizabeth Nabel. 9. Poon M., Dinh H., Fuster V.
MRI of the Heart (Excluding Coronary Imaging)
In Hurst’s the Heart
, 11th edition ed by Valentin Fuster
10. Nikolaou K., Poon M., Fuster V., Fayad Z.
MRI and CT of the Vascular System
In Hurst’s the Heart
, 11th edition ed by Valentin Fuster
11. Poon M., Sanz J., Zhao P.
The Role of CMR in the Clinical Presentation of Acute Coronary Syndromes
In Atherosclerosis and Coronary Artery Disease,
2nd edition, Ed by Valentin Fuster, Eric Toprol, and Elizabeth Nabel. Publications: (chapters in books) (continued):
12.
Nikolaou K., Poon M., Fuster V., Fayad Z.
Noninvasive Imaging of the Vascular System
In Atherosclerosis and Coronary Artery Disease,
2nd edition, Ed by Valentin Fuster, Eric Toprol, and Elizabeth Nabel 13. Howard V Dinh, Jeffrey P Goldman , Michael Poon
CMR in the assessment of pulmonary hypertension
Cardiovascular Magnetic Resonance (Established and Emerging Applications) Ed by: Albert Lardo, Zahi Fayad, Nicolas Chronos, Valentin Fuster 14. Phillip Yang, Michael Poon, James Vitarius, Gerald M Pohost
Magnetic Resonance Imaging of the Heart in Coronary Arter Disease
Atherothrombosis and Coronary Artery Disease Ed by Valentin Fuster, Eric J Topol, Elizabeth G Nabel 15. Michael Poon, Javier Sanz, Phillip T Zhao
Magnetic Resonance Imaging in the Clinical Presentation of Acute Coronary
Atherothrombosis and Coronary Artery Disease Ed by Valentin Fuster, Eric J Topol, Elizabeth G Nabel
16. Konstantin Nikolaou, Michael Poon, Valentin Fuster, Zahi Fayad
Noninvasive Imaging of the Vascular System – The Role of Magnetic Resonance
Imaging and Computed Tomography
Atherothrombosis and Coronary Artery Disease 2nd Edition, Ed by Valentin Fuster, Eric J Topol, Elizabeth G Nabel Publications: (chapters in books) (continued):

17. Michael Poon, Howard V Dinh, Valentin Fuster
Magnetic Resonance Imaging of the Heart
11th Edition, Ed by Valentin Fuster, R.Wayne Alexander, Robert A O’Rourke, Robert Roberts, Spencer B King III, Ira S Nash, Eric N. Prystowsky 18. Konstantin Nikolaou, Michael Poon, Valentin Fuster, Zahi Fayad
Magnetic Resonance Imaging and computed Tomography of the Vascular System
11th Edition, Ed by Valentin Fuster, R.Wayne Alexander, Robert A O’Rourke, Robert Roberts, Spencer B King III, Ira S Nash, Eric N. Prystowsky Publications (ELECTRONIC PUBLICATIONS):
1. Poon M. The 34th Annual New York Cardiovascular Symposium Volume 2.
New Advances in Pulmonary HypertensioN
Boston: Physician Education, Inc.; 2002. (CD-ROM)
2. Poon, M., Fuster V.
MRI: Is It a Crystal Ball of Medicine?
Hurst’s The Heart
(http://cardiology.accessmedicine.com), McGraw Hill 2001-2002. 3. Poon, M., Fuster V.
CONCISE REVIEW: Non-invasive Assessment of Coronary Vein Graft Stenosis
Using MRI? Hurst’s The Heart
(http://cardiology.accessmedicine.com), McGraw Hill 2001-2002. 4. Poon, M., Ritu Sharma, Fuster V.
Primary Results of the CHAMPS Study: Are Combined Warfarin and Aspirin Too
Much of a Good Thing? Hurst’s The Heart
(http://cardiology.accessmedicine.com), McGraw Hill 2001-2002. 5. Goldman, J., Poon, M.
GE Diagnostic MRI Imaging: Concentric LV Hypertrophy
(http://apps.gemedicalsystems.com/geCommunity/mri/mr_i/clinical_cases/cotw26_files/ 6. Goldman, J., Poon, M.
GE Diagnostic MRI Imaging: Detection of Fibromuscular Dysplasia
using Signa CV/i 1.5T
7. Goldman, J., Poon, M.
GE Diagnostic MRI Imaging: Detection of Left Subclavian Artery Aneurysm
GE Diagnostic MRI Imaging
8. Goldman, J., Poon, M.
GE Diagnostic MRI Imaging: Aortic Arch Aneurysm
9. Dinh, H., Sulica, R, Fuster, V.,Poon, M
Epoprostenol Prolongs Survival in Primary Pulmonary Hypertension
(http://cardiology.accessmedicine.com), McGraw Hill 2001-2002. 10. Sulica R, Dinh, H., Fuster, V., Poon, M
Beneficial Effect of Acute Sildenafil Administration in Pulmonary Hypertension
Secondary to Pulmonary Fibrosis
(http://cardiology.accessmedicine.com), McGraw Hill 2001-2002. 11. Poon, M., Fuster V., Sanz J
Pushing the Envelope in Cardiac Magnetic Resonance (CMR): Delineation of
Subendomyocardial Infarction
(http://cardiology.accessmedicine.com), McGraw Hill 2001-2002. 12. Poon, M., Fuster V., Sanz J
Evaluation of ischemic heart disease with cardiac magnetic Resonance (CMR)
and computed tomography
MAJOR PROFESSIONAL PRESENTATIONS (Since promotion to Associate
Professor):
1. June 8, 2003, Scientific Conference of the American Heart Association - High
Risk Plaques: New Understanding and Approach
TITLE: Selecting Patients for Atherothrombosis Imaging
2. July 26, 2003 4th International Conference on Cardiac Spiral CT
TITLE: Case Presentation and Chair of the Session on Contributed Paper III:
Clinical Aspects
(www.massgeneralimaging.org/CardiacCT4)
3. November 8, 2003, Men's Health Disorders 2003
TITLE: Cardiovascular Disease: The Role of Cardiac Imaging In Early Detection
4. November 15, 2003, CBS News, New York, CBS2
TITLE: HealthWatch Report: New Ways to Detect Heart Trouble

MAJOR PROFESSIONAL PRESENTATIONS (continued)

5. December 21, 2003, 36th Annual New York Cardiovascular Symposium
TITLE: Cardiac MR/CT Imaging: State of the Art
(http://www.scmr.org/meetings/scmr2004brochure.pdf)

6. Feb 4, 2004 PCOM Meetings: Centers for Medical and Medicaid Services (CMS)
TITLE: Multi-slice Computerized Tomography of the Chest.
7. Feb 12, 2004, Seven Annual SCMR Scientific Sessions/Euro CMR 2004 Meeting
TITLE: Pulmonary Hypertension and CMR
8. March 8, 2004, CBS News, Philadelphia, KYW
TITLE: Health Report: CT-MR

9. March 20, 2004, American College of Cardiology 2004 Scientific Sessions

TITLE: Clinical Crossfire: EBCT vs Multi-slice CT
10. March 28, 2004, The 68th Annual Scientific Meeting of the Japanese Circulation
TITLE: Keynote Lecture (FRS9): Comprehensive Assessment of Ischemic Heart
Disease wth Cardiac Magnetic Resonance (CMR) and Computed Tomography
11. March 28, 2004, The 68th Annual Scientific Meeting of the Japanese Circulation
TITLE: Fireside Seminar: Clinical Cardiac CT Imaging – State of the Art
MAJOR PROFESSIONAL PRESENTATIONS (continued)
12. March 30, 2004, Solvay Pharmaceuticals Men’s Health Medical Liaison
Preceptorship Program in New York City
TITLE: Cardiovascular Disease and Hypogonadism: Issues of Common Concern.
13. April 29, 2004, Robert M. Jeresaty MD Cardiovascular Symposium
St. Francis Hospital and Medical Center, Hartford, CT 06105
TITLE: Advanced Cardiac Imaging in the Assessment of Pulmonary Hypertension

14. May 4, 2004, Grand Rounds, Montefiore Hospital – Bronx, NY
TITLE: Diagnostic Approach and Management of Pulmonary Artery
Hypertension
15. May 27, 2004, Grand Rounds, Newark Beth Israel
TITLE: Non-invasive Imaging of Pulmonary Hypertension
16. July 30, 2004, Hospital of San Donato, Milan, Italy
TITLE: Cardiac MR Imaging in the Treatment of Advanced Congestive Heart
17. August 7, 2004, CORE meeting – New York, NY
TITLE: Advance Cardiac MR/CT Imaging
18. August 14, 2004, Colorado Spring, CO
TITLE: Cardiac CT Imaging – State of the Art
MEDCATH Incorporated Scientific Advisory Board Meeting
MAJOR PROFESSIONAL PRESENTATIONS (continued)
19. September 12, 2004, Cardiovascular MR Nat’l Symposium - Orlando, Florida
TITLE: Cardiac MRI and MRA in the Assessment of Right Heart Failure and
Pulmonary Hypertension
20. September 13, 2004, Cardiovascular Imaging Conference – Chicago Illinois
TITLE: The Role of Combined Cardiac CT and MR Imaging
21. September 30, 2004 – ASNC Conference – Hilton Hotel, New York
MODERATOR
22. October 8, 2004, Cardiac Catherization Conference - Morristown Hospital -
Morristown, NJ
TITLE: Updates on Today’s Cardiac CT
23. October 18, 2004, Grand Rounds – Cabrini Medical Ctr - NYC
TITLE: Diagnostic and Mgmt of PH
24. November 8, 2004, Support Groups PPH Conference – Sarasota, Florida
TITLE: Diagnostic & Mgmt of PH
25. December 7, 2004, PH Conference – Wynthrop Hospital - Mineola
TITLE: Advanced Diagnostic Imaging for PH
26. December 11, 2004, 37th Cardiovascular Symposium – NY Hilton, New York
TITLE: Novel Approaches to MRI/CT in Valvular and Nonvalvular Defects in Heart
Disease.
MAJOR PROFESSIONAL PRESENTATIONS (continued)
27. December 21, 2004, Cardiac Conference Victory Memorial Hospital –
Brooklyn, NY
TITLE: Combined cardiac MR/CT imaging: State of the Art
28. January 31, 2005, Grand Rounds – Beth Israel Hospital, New York, NY
TITLE: Advanced Cardiac Imaging with Cardiac MR & CT
29. February 2, 2005, Grand Rounds – Brawerd General Hosp, Ft. Lauderale FL.
TITLE: Advanced Diagnostic Imaging for PH
30. February 3, 2005, Grand Rounds – Advocate Christ Med Ctr, Chicago, IL
TITLE: Combined Cardiac Computed Tomography and MRI Imaging in the
evaluation of Complex Cardiovascular Disease
31. February 8, 2005, Grand Round – Elmhurst Medical Center, New York, NY
TITLE: Advanced Cardiac Imaging with Cardiac MR & CT
32. February 9, 2005, Grand Round – Danbury Hospital, Danbury, CT
TITLE: Advanced Diagnostic Imaging for PH
33. February 24, 2005 – Cardiovascular Imaging Conference – New Orleans, LA
TITLE: The Role of Combined Cardiac CT and MR Imaging
34. March 11, 2005 – Grand Rounds – St. Vincents Hospital – New York, NY
TITLE: Advanced Cardiac Imaging for PH
MAJOR PROFESSIONAL PRESENTATIONS (continued)
35. March 24, 2005 - SCBT/MR – South Beach, Florida
TITLE: Cardiac CT & MR (Workstation Showdown)
36. April 6, 2005 – Grand Rounds – Mountainside Hospital – New Jersey
TITLE: Thin Slice CT Coronaries
37. April 9, 2005 – NJ Chapter Annual Meeting – West Orange, NJ
TITLE: Advanced Cardiovascular Imaging Using Combined CT and MR
38. April 11, 2005 – Grand Rounds – Lutheran Hospital – Brooklyn, NY
TITLE: Cardiac CT Imaging – State of the Art
39. April 29-30, 2005 - Wisconsin Heart Hospital – Milwaukee, Wisconsin
TITLE: 1. Why should a Cardiologist be interested in CTA – How does CTA work.
2. Drilling Down on CTA and the Business of CTA
3. Cardiac CTA post-processing.

Source: http://medram.com.ua/files/21-140-42.pdf

Hábitos saludables tras un infarto

Recomendaciones sobre hábitos saludables tras sufrir un Infarto de Miocardio Tras sufrir un Infarto de Miocardio, nos asaltan dudas acerca de la idoneidad de multitud dehábitos o factores ligados a nuestra vida diaria. La persona que ha sufrido un Infarto, abandona elhospital con la sensación (en mayor o menor medida dependiendo de la persona) de gran limitación,de haber quedado mermados a

Microsoft word - chavaniac anglais jwh.doc

History Chavaniac-Lafayette , The history of a small village in Auvergne that became a place of historical importance . Situated within the confines of the Monts de Velay, in the plains of Chaliergue, Chavanhac was successively known as Chanvaniac (Xth Century), Javaniac (XIIth Century), Cavanhac (XVth Century) and then as Chavaniac. Of Gallo-Roman origin and located in the Canton of P

Copyright © 2010 Medicament Inoculation Pdf